• News
  • Medical

Carol Cox named executive VP at NuVasive

NuVasive Inc. (Nasdaq: NUVA) announced that Carol Cox has joined the company as executive vice president of Strategy and Corporate Communications, effective immediately. She will report directly to Alex Lukianov, chairman and CEO of NuVasive, and will join the company's executive committee.

In this newly created role, Cox will be responsible for leading NuVasive's short- and long-term business strategies, as well as creating and managing a centralized communications function to ensure global alignment of messaging and leveraging of assets across the key areas of corporate communications, investor relations and public affairs. Included in Cox's responsibilities will also be overseeing NuVasive corporate philanthropic and cultural efforts.

Cox is an executive with global health care experience in corporate strategy, investor relations, corporate communications, media relations, brand strategy and government relations. She joins NuVasive from Sanford-Burnham Medical Research Institute where she served as senior vice president of external affairs, leading external and internal communications, philanthropy, marketing, government relations and efforts to elevate the institute's global recognition.

Prior to Sanford-Burnham, she served as senior vice president of External Affairs and Corporate Communications at Life Technologies, where she spearheaded global strategies to drive awareness of the company's major initiatives, enhance its global brand, and maintain its corporate reputation across multiple stakeholder groups. Before joining Life Technologies, Cox was vice president of Investor Relations at CareFusion Corp. and senior vice president for Global Corporate Communications and Investor Relations at Barr Pharmaceuticals.

She holds a bachelor's of arts degree in foreign affairs from the University of Virginia and a certificate in Investor Relations from The University of Connecticut School of Business.

User Response
0 UserComments